Latest Technology Platform News

Sequoia Financial Group reported a sharp first-quarter revenue decline and pretax loss as authorised representatives left its InterPrac licence. Cash rose to A$11.4 million, but the balance was bolstered by the sale of Centrepoint Alliance shares while ASIC continues to question documentation linked to the InterPrac exit.

Carma delivered record Q1 FY2027 revenue of $44.3 million and gross profit of $3.5 million after retail vehicle sales more than doubled year on year. The stronger trading result came with lower total gross profit per unit and $10.2 million of operating cash outflow.

Zeotech has begun an approximately 800-tonne commercial-scale AusPozz production trial while reporting independently replicated mining test results and a 92% average methane reduction in treated landfill cells. The September quarter also brought a non-binding VINCI Construction MOU, further Toondoon resource work and A$6.609 million in cash.

Cochlear has reaffirmed FY27 underlying net profit guidance of $330 million to $350 million after a disappointing FY26, while pointing to strong Nexa adoption and progress on fully implantable hearing technology. The company is cutting fixed costs and expanding medical referral pathways as it seeks to convert a large pool of untreated adult hearing loss into growth.

Lithium Universe’s CEO and chief technical officer will leave on 30 October, prompting a search for a new chief executive while the company advances its lithium refining and recycling plans. No interim CEO or successor has been announced.

Adslot reported stronger Viber advertising activity and lower operating costs in the September quarter, while restructuring payments continued to weigh on cash. The company ended the period with $1.28 million and a prescribed funding runway of 1.7 quarters.

Airtasker delivered its strongest GMV growth in four years in FY26, but the expansion still consumed cash as international investment accelerated. The ASX-listed marketplace is now targeting positive free cash flow in FY27 while scaling membership and reducing UK investment.

Orcoda has opened FY27 with unaudited quarterly revenue of $6.2 million, up 63% from the previous quarter, while annual recurring revenue reached approximately $14.7 million. The strongest contribution came from its Resource and Infrastructure division, where revenue more than doubled as the company reduced reliance on a single major customer.

Locality Planning Energy has returned to statutory profit and sharply reduced borrowings, but its next test is converting a large contracted pipeline into active service points. The company has given no numerical FY2027 guidance and is operating under an interim leadership structure while it searches for a permanent CEO.

Noxopharm says the FDA has supported its proposed Phase II design and chemical manufacturing strategy for SOF-SKN, its topical treatment candidate for cutaneous lupus erythematosus. The feedback improves regulatory clarity, but the trial remains targeted for the first half of calendar 2028 and is subject to further studies and regulatory requirements.

Compumedics Limited (ASX:CMP) returned to profit in FY26 as record revenue, stronger cash generation and a sharp rise in MEG and SaaS sales reshaped its earnings profile. The company enters FY27 with A$28.3 million of open orders, but lower gross margins and uneven US and European execution remain key tests.

Viva Leisure used FY2026 to prove its existing club network could generate stronger returns without rapid expansion, lifting revenue 12.2% and underlying NPAT 46.4%. The ASX-listed fitness group is now preparing to accelerate openings while reviewing options for its faster-growing payments and technology business.